Friday, January 06, 2023 2:33:32 PM
Yes, there were Buyout talks with other Co's a couple of years ago, but they were just preliminary meetings to see what RGBP was all about, nothing more! If I'm not mistaken, one or maybe 2 Co's told RGBP that we had to meet certain requirements before they would meet again? It's only natural to see Co's wanting to see concrete steps being taken, where it would help them to gain revenues sooner than later!
Also, like Insurance Co's, there probably were a few LOW bids, but were too low, as Koos thought that there was too much potential to be low-balled, and refused? Evidently Koos has somewhat of a treasure chest to pay the bills, something few Investors have! But all in All, there doesn't seem anything to stop the progress, which can only be slow? But when PRs start coming in, they will be VERY GOOD ONES, as the developmental issues are long gone! We should hear news about Clinical trials for at least ONE pharmaceutical agent, maybe 2, as a few seem to enter the trials close after one another a year or two ago! But close may mean years instead of Months, I don't know, and clearing trial 1 may only mean that the next Clinical trial (2 or 3) is soon to be launched if the money is there? Maybe a trial may be in stage 2, and that is quite possible?
As I mentioned before, I bought into NASTECH PHARMACEUTICALS INC. a number of years ago, and at $.18 cents a share! But Bad Luck hit me as I had substantial bills to pay and had to sell-out! I forgot about it due to severe circumstances, but one day a few years later, I had the guts to look at NASD, I think the symbol was, and I was disheartened because the stock rose to $ 23+ Dollars a share! Yes, 23+ Bucks a share!! That's the way it is in this Penny sector! The best to all, and a healthy 2023!! T.
Recent HYSR News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/03/2024 08:06:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 08:05:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/21/2024 07:32:27 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 09:01:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2024 09:31:40 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/02/2024 05:15:09 AM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 01/25/2024 09:40:59 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/24/2024 09:32:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 08:28:16 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/29/2023 09:03:04 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/29/2023 08:33:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 08:13:34 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM